129 related articles for article (PubMed ID: 31016793)
1. TWIST1, MMP-21, and HLAG-1 co-overexpression is associated with ESCC aggressiveness.
Golyan FF; Abbaszadegan MR; Forghanifard MM
J Cell Biochem; 2019 Sep; 120(9):14838-14846. PubMed ID: 31016793
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between MMP-13, CD44, and TWIST1 and its role in regulation of EMT in patients with esophageal squamous cell carcinoma.
Mahmoudian RA; Gharaie ML; Abbaszadegan MR; Alasti A; Forghanifard MM; Mansouri A; Gholamin M
Mol Cell Biochem; 2021 Jun; 476(6):2465-2478. PubMed ID: 33604811
[TBL] [Abstract][Full Text] [Related]
3. TWIST1 correlates with Notch signaling pathway to develop esophageal squamous cell carcinoma.
Fahim Y; Yousefi M; Izadpanah MH; Forghanifard MM
Mol Cell Biochem; 2020 Nov; 474(1-2):181-188. PubMed ID: 32712748
[TBL] [Abstract][Full Text] [Related]
4. A new gene panel as a marker for ESCC poor prognosis; INPP5A, TWIST1, MMP2, and EGFR.
Fardi Golyan F; Forghanifard MM
Adv Med Sci; 2021 Sep; 66(2):231-236. PubMed ID: 33798953
[TBL] [Abstract][Full Text] [Related]
5. INPP5A/HLA-G1/IL-10/MMP-21 Axis in Progression of Esophageal Squamous Cell Carcinoma.
Ardalan Khales S; Aarabi A; Abbaszadegan MR; Forghanifard MM
Iran Biomed J; 2022 Nov; 26(6):440-53. PubMed ID: 36437782
[TBL] [Abstract][Full Text] [Related]
6. Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition.
Lee KW; Kim JH; Han S; Sung CO; Do IG; Ko YH; Um SH; Kim SH
Ann Surg Oncol; 2012 Jan; 19(1):326-35. PubMed ID: 21732143
[TBL] [Abstract][Full Text] [Related]
7. Expression analysis elucidates the roles of MAML1 and Twist1 in esophageal squamous cell carcinoma aggressiveness and metastasis.
Forghanifard MM; Moaven O; Farshchian M; Montazer M; Raeisossadati R; Abdollahi A; Moghbeli M; Nejadsattari T; Parivar K; Abbaszadegan MR
Ann Surg Oncol; 2012 Mar; 19(3):743-9. PubMed ID: 22006371
[TBL] [Abstract][Full Text] [Related]
8. TWIST1 upregulates matrix metalloproteinase (MMP) genes family in esophageal squamous carcinoma cells.
Ardalan Khales S; Abbaszadegan MR; Majd A; Forghanifard MM
Gene Expr Patterns; 2020 Sep; 37():119127. PubMed ID: 32711119
[TBL] [Abstract][Full Text] [Related]
9. MAML1 promotes ESCC aggressiveness through upregulation of EMT marker TWIST1.
Forghanifard MM; Azaraz S; Ardalan Khales S; Morshedi Rad D; Abbaszadegan MR
Mol Biol Rep; 2020 Apr; 47(4):2659-2668. PubMed ID: 32180088
[TBL] [Abstract][Full Text] [Related]
10. Linkage between EMT and stemness state through molecular association between TWIST1 and NY-ESO1 in esophageal squamous cell carcinoma.
Ardalan Khales S; Abbaszadegan MR; Majd A; Forghanifard MM
Biochimie; 2019 Aug; 163():84-93. PubMed ID: 31158427
[TBL] [Abstract][Full Text] [Related]
11. Correlation between the immune checkpoints and EMT genes proposes potential prognostic and therapeutic targets in ESCC.
Mahmoudian RA; Mozhgani S; Abbaszadegan MR; Mokhlessi L; Montazer M; Gholamin M
J Mol Histol; 2021 Jun; 52(3):597-609. PubMed ID: 33884540
[TBL] [Abstract][Full Text] [Related]
12. TWIST1 upregulates the MAGEA4 oncogene.
Forghanifard MM; Rad A; Farshchian M; Khaleghizadeh M; Gholamin M; Moghbeli M; Abbaszadegan MR
Mol Carcinog; 2017 Mar; 56(3):877-885. PubMed ID: 27533647
[TBL] [Abstract][Full Text] [Related]
13. Ectopic expression of TWIST1 upregulates the stemness marker OCT4 in the esophageal squamous cell carcinoma cell line KYSE30.
Izadpanah MH; Abbaszadegan MR; Fahim Y; Forghanifard MM
Cell Mol Biol Lett; 2017; 22():33. PubMed ID: 29299035
[TBL] [Abstract][Full Text] [Related]
14. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
15. CD10 expression is enhanced by Twist1 and associated with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro and in vivo.
Lee KW; Sung CO; Kim JH; Kang M; Yoo HY; Kim HH; Um SH; Kim SH
Int J Cancer; 2015 Jan; 136(2):310-21. PubMed ID: 24895167
[TBL] [Abstract][Full Text] [Related]
16. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
[TBL] [Abstract][Full Text] [Related]
17. Increased MMP-21 expression in esophageal squamous cell carcinoma is associated with progression and prognosis.
Zhao Z; Yan L; Li S; Sun H; Zhou Y; Li X
Med Oncol; 2014 Aug; 31(8):91. PubMed ID: 25015395
[TBL] [Abstract][Full Text] [Related]
18. MAML1 and TWIST1 co-overexpression promote invasion of head and neck squamous cell carcinoma.
Ardalan Khales S; Ebrahimi E; Jahanzad E; Ardalan Khales S; Forghanifard MM
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e434-e441. PubMed ID: 29333702
[TBL] [Abstract][Full Text] [Related]
19. CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1.
Zeng TD; Zheng B; Zheng W; Chen C
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5928-5937. PubMed ID: 30280774
[TBL] [Abstract][Full Text] [Related]
20. MTA2 promotes the metastasis of esophageal squamous cell carcinoma via EIF4E-Twist feedback loop.
Dai SL; Wei SS; Zhang C; Li XY; Liu YP; Ma M; Lv HL; Zhang Z; Zhao LM; Shan BE
Cancer Sci; 2021 Mar; 112(3):1060-1074. PubMed ID: 33340431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
